Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity

NCT05247671 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05247671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Unknown status
Start date
February 15, 2022
Completion date
December 15, 2022
Enrollment
89 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cisplatin adverse reaction